News & CommentHuman Genome Project

Funders Reassure Genome Sequencers

See allHide authors and affiliations

Science  22 May 1998:
Vol. 280, Issue 5367, pp. 1185
DOI: 10.1126/science.280.5367.1185

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


COLD SPRING HARBOR, NEW YORK-- Last week's stunning announcement by J. Craig Venter, president of The Institute for Genomic Research in Rockville, Maryland, that he plans to team up with the Perkin-Elmer Corp. of Norwalk, Connecticut, to form a new company to sequence the human genome in 3 years (Science, 15 May, p. 994) dominated an international meeting of genome researchers here last week, even though Venter himself wasn't present. Because many of the meeting participants are involved in a vast public program to do the same thing by 2005, the subtext of the gathering was: What does Venter's proposal do to our plans? For the most part, the researchers were reassured by the announcement from the United Kingdom's Wellcome Trust that it would double its investment in the international sequencing project and the assurances from Francis Collins, director of the National Human Genome Research Institute, that the U.S. Human Genome Project would continue as planned.